Dyphylline - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for dyphylline and what is the scope of patent protection?
Dyphylline
is the generic ingredient in four branded drugs marketed by Teva, Savage Labs, and Pharmobedient, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.Summary for dyphylline
| US Patents: | 0 |
| Tradenames: | 4 |
| Applicants: | 3 |
| NDAs: | 5 |
| Drug Master File Entries: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 104 |
| DailyMed Link: | dyphylline at DailyMed |
Medical Subject Heading (MeSH) Categories for dyphylline
US Patents and Regulatory Information for dyphylline
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmobedient | LUFYLLIN | dyphylline | TABLET;ORAL | 084566-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Savage Labs | DILOR-400 | dyphylline | TABLET;ORAL | 084751-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Teva | NEOTHYLLINE | dyphylline | TABLET;ORAL | 007794-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Teva | NEOTHYLLINE | dyphylline | TABLET;ORAL | 007794-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
